Lipocine Inc. - Common Stock —— 季度现金流量表 (NASDAQ:LPCN) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 22.51 M20.5 M18.58 M16.07 M17.01 M25.36 M 负债总额 1.51 M1.3 M1.45 M1.93 M2.53 M2.53 M 权益总额 21 M19.2 M17.13 M14.14 M14.48 M22.83 M 负债及股东权益总额 22.51 M20.5 M18.58 M16.07 M17.01 M25.36 M 总债务 —————— 净债务 ——————

新闻

Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates

BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue Estimates

美国股市涨跌不一；截至收盘道琼斯工业平均指数下跌0.13%

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%

Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock?

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Lipocine completes patient visits in phase 3 trial for PPD treatment

H.C. Wainwright上调Lipocine目标股价至15美元，因PPD试验进展

H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress

Lipocine completes enrollment in phase 3 trial for PPD treatment

利波辛公司产后抑郁症药物试验在安全性评估后继续进行

Lipocine’s PPD drug trial continues after positive safety review